StreetInsider.com News Articles

Form 6-K NuCana plc For: Jun 08

Mon, 08 Jun 2026 07:52:00 -0400

si-local-file:///var/storage/secattach/20260608/26614382.html

Form 6-K NuCana plc For: Jun 08

Mon, 08 Jun 2026 07:52:00 -0400

si-local-file:///var/storage/secattach/20260608/26614382.html

Form 6-K NuCana plc For: Jun 01

Mon, 01 Jun 2026 08:13:00 -0400

si-local-file:///var/storage/secattach/20260601/26579701.html

Form 6-K NuCana plc For: Jun 01

Mon, 01 Jun 2026 08:13:00 -0400

si-local-file:///var/storage/secattach/20260601/26579701.html

NuCana names Ian Webster as chief financial officer

Mon, 01 Jun 2026 08:00:20 -0400

NuCana plc (NASDAQ: NCNA) appointed Ian Webster as chief financial officer, effective June 1. Webster had served as interim chief financial officer since June 2025 and previously held the role of director of finance since joining the clinical-stage biopharmaceutical company in 2019.

Webster brings over 20 years of finance experience, including more than a decade in senior leadership positions within the biopharmaceutical sector. His background includes financial management, public company reporting, audit, tax, mergers and acquisitions, and financial planning and analysis.

Before joining NuCana, Webster served as group financial controller at Kyowa Kirin International plc from 2013 to 2019. He previously spent

NuCana Appoints Ian Webster as Chief Financial Officer

Mon, 01 Jun 2026 08:00:00 -0400

EDINBURGH, United Kingdom, June 01, 2026 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer, announced the appointment of Ian Webster as Chief Financial Officer, effective today. Ian has served as Interim Chief Financial Officer since June 2025 and was previously Director of Finance since joining NuCana in 2019.

“We are delighted to appoint Ian as Chief Financial Officer,” said Hugh S. Griffith, Founder and Chief Executive Officer of NuCana. “Since joining NuCana, Ian has demonstrated deep financial expertise

NuCana Appoints Ian Webster as Chief Financial Officer

Mon, 01 Jun 2026 08:00:00 -0400

Form 6-K NuCana plc For: May 14

Thu, 14 May 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20260514/26496077.html

Form 6-K NuCana plc For: May 14

Thu, 14 May 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20260514/26496077.html

NuCana Reports First Quarter 2026 Financial Results and Provides Business Update

Thu, 14 May 2026 16:01:00 -0400

Final Data from Phase 2 Expansion Study of NUC-7738 Expected in 2026

NUC-7738 Receives FDA IND Clearance: Planned Initial Studies to Focus on Melanoma

Advancing Additional Indications and Combination Strategies

Cash Runway Expected to Extend into 2029

EDINBURGH, United Kingdom, May 14, 2026 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) today announced financial results for the first quarter ended March 31, 2026 and provided an update on its clinical development program with its two lead anti-cancer medicines.

"We are pleased to report

NuCana Reports First Quarter 2026 Financial Results and Provides Business Update

Thu, 14 May 2026 16:01:00 -0400

Final Data from Phase 2 Expansion Study of NUC-7738 Expected in 2026

NUC-7738 Receives FDA IND Clearance: Planned Initial Studies to Focus on Melanoma

Advancing Additional Indications and Combination Strategies

Cash Runway Expected to Extend into 2029

"We are pleased to report

Form 6-K NuCana plc For: May 06

Wed, 06 May 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260506/26443725.html

Form 6-K NuCana plc For: May 06

Wed, 06 May 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260506/26443725.html

Form 4 NuCana plc For: Apr 15 Filed by: Bruce Theresa Margaret Ms

Thu, 16 Apr 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260416/26325647.html

Form 4 NuCana plc For: Apr 15 Filed by: Bruce Theresa Margaret Ms

Thu, 16 Apr 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260416/26325647.html

Form 3 NuCana plc For: Mar 18 Filed by: Levy Elliott M.

Wed, 01 Apr 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260401/26259821.html

Form 3 NuCana plc For: Mar 18 Filed by: Levy Elliott M.

Wed, 01 Apr 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260401/26259821.html

Form 3 NuCana plc For: Mar 18 Filed by: Harrison David James

Tue, 24 Mar 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260324/26210755.html

Form 3 NuCana plc For: Mar 18 Filed by: Harrison David James

Tue, 24 Mar 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260324/26210755.html

Form 3 NuCana plc For: Mar 18 Filed by: Mellish Martin C.B.

Fri, 20 Mar 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260320/26197862.html

Form 3 NuCana plc For: Mar 18 Filed by: Mellish Martin C.B.

Fri, 20 Mar 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260320/26197862.html

Form 3 NuCana plc For: Mar 18 Filed by: Bloss Jeffrey D.

Thu, 19 Mar 2026 17:52:00 -0400

si-local-file:///var/storage/secattach/20260319/26193860.html

Form 3 NuCana plc For: Mar 18 Filed by: Bloss Jeffrey D.

Thu, 19 Mar 2026 17:52:00 -0400

si-local-file:///var/storage/secattach/20260319/26193860.html

Form S-8 NuCana plc

Thu, 19 Mar 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260319/26193728.html

Form S-8 NuCana plc

Thu, 19 Mar 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260319/26193728.html